Constipation and Constipation-predominant Irritable Bowel Syndrome: A Comparative Study Using Rome III Criteria

被引:19
|
作者
Rajindrajith, Shaman [1 ]
Devanarayana, Niranga M. [2 ]
Benninga, Marc A. [3 ]
机构
[1] Univ Kelaniya, Fac Med, Dept Paediat, Ragama, Sri Lanka
[2] Univ Kelaniya, Fac Med, Dept Physiol, Ragama, Sri Lanka
[3] Emma Childrens Hosp, Acad Med Ctr, Dept Paediat Gastroenterol & Nutr, Amsterdam, Netherlands
关键词
child abuse; constipation; irritable bowel syndrome; prevalence; somatization; QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; CHRONIC IDIOPATHIC CONSTIPATION; PEDIATRIC-PATIENTS; CHILDREN; ASSOCIATION; SYMPTOMS; SYMPTOMATOLOGY; ADOLESCENTS; PREVALENCE;
D O I
10.1097/MPG.0000000000001332
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: The aim of the present study is to compare functional constipation (FC) and constipation-predominant irritable bowel syndrome (IBS-C) in adolescents. Methods: A school-based survey was conducted involving adolescents ages 13 to 18 years. A set of validated questionnaires including Rome III questionnaire for functional gastrointestinal disorders in children/adolescents, somatization inventory, quality of life inventory, and childhood traumatic events inventory were used for data collection. FC and IBS-C were defined using Rome III criteria. Results: A total of 1792 adolescents (975 boys [45.4%]) were included in the analysis. Prevalence of FC and IBS-C were 7.7% and 1.6%, respectively. Bowel habits such as stool frequency < 3 per week (10% vs 44.9%, P < 0.0001), hard stools (20% vs 40.5%, P < 0.05), painful defecation (33.3% vs 56.5%, P < 0.05), large diameter stools (23.3% vs 50.7%, P < 0.01), stool withholding behavior (20% vs 44.2%, P < 0.05), were more commonly associated with FC than did IBS-C. Occurrence of fecal incontinence (0% vs 8%, P = 0.21), urgency (56.7% vs 66.7%, P = 0.65), and straining (56.7% vs 36.9%, P = 0.47) was not significantly different between IBS-C and FC. Exposure to physical abuse, emotional abuse, and sexual abuse was equally prevalent among adolescents with FC and IBS-C. There was no difference between somatization scores, and health-related quality of life between the 2 groups. Conclusions: Although bowel habits related to stool withholding are more prevalent in FC, than in IBS-C, they are more likely to be a spectrum of a disorder rather than 2 separate entities.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 50 条
  • [41] How effective is fluoxetine for the treatment of pain and constipation-predominant irritable bowel syndrome?
    Nicholas J Talley
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 196 - 197
  • [42] Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome: The Puzzle Is Yet to Be Solved
    Sachdeva, Sanjeev
    Kondala, Raghuram
    Dahale, Amol Sonyabapu
    Puri, Amarender Singh
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (11) : 2836 - 2837
  • [43] Constipation-predominant irritable bowel syndrome: A review of current and emerging drug therapies
    Khaled A Jadallah
    Susan M Kullab
    David S Sanders
    [J]. World Journal of Gastroenterology, 2014, 20 (27) : 8898 - 8909
  • [44] A 54-year-old woman with constipation-predominant irritable bowel syndrome
    Lembo, AJ
    Reynolds
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (08): : 925 - 933
  • [45] Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome: The Puzzle Is Yet to Be Solved
    Sanjeev Sachdeva
    Raghuram Kondala
    Amol Sonyabapu Dahale
    Amarender Singh Puri
    [J]. Digestive Diseases and Sciences, 2014, 59 : 2836 - 2837
  • [46] Inability of the Rome III Criteria to Distinguish Functional Constipation From Constipation-Subtype Irritable Bowel Syndrome
    Wong, Reuben K.
    Palsson, Olafur S.
    Turner, Marsha J.
    Levy, Rona L.
    Feld, Andrew D.
    von Korff, Michael
    Whitehead, William E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (10): : 2228 - 2234
  • [47] Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
    Prather, CM
    Camilleri, M
    Zinsmeister, AR
    McKinzie, S
    Thomforde, G
    [J]. GASTROENTEROLOGY, 2000, 118 (03) : 463 - 468
  • [48] Effect of bifidogenic growth stimulator on patients with constipation-predominant irritable bowel syndrome
    Amano, Tomofumi
    Ariga, Hajime
    Yamato, Shigeru
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A552 - A552
  • [49] Differentiation of Functional Constipation (FC) and Irritable Bowel Syndrome-Constipation Predominant (IBS-C) Based on ROME III Criteria. A Population Based Study
    Koloski, Natasha A.
    Jones, Michael P.
    Young, Melissa
    Talley, Nicholas J.
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S354 - S354
  • [50] Durability and Predictability of Treatment Response to Lubiprostone in Patients With Constipation-Predominant Irritable Bowel Syndrome
    Fass, Ronnie
    Chey, William D.
    Wang, Martin
    Mareya, Shadreck
    Losch-Beridon, Taryn
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S761 - S761